---
title: "Sensei Biotherapeutics, Inc. (SNSE.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SNSE.US.md"
symbol: "SNSE.US"
name: "Sensei Biotherapeutics, Inc."
industry: "Biotechnology"
datetime: "2026-05-21T13:43:21.067Z"
locales:
  - [en](https://longbridge.com/en/quote/SNSE.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SNSE.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SNSE.US.md)
---

# Sensei Biotherapeutics, Inc. (SNSE.US)

## Company Overview

Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company’s pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [www.senseibio.com](https://www.senseibio.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.13 | 82 | - | - | - |
| PB | -0.17 | 465 | 1.52 | 0.48 | 0.35 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-18T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 17.65 |
| Highest Target | 50.00 |
| Lowest Target | 50.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/SNSE.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/SNSE.US/norm.md)
- [Related News](https://longbridge.com/en/quote/SNSE.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/SNSE.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**